Tax Rate: 20.62%
Is the tax rate high or low?
The tax rate of 20.62% is 15% below its 5-year average of 24.32%, near the low end of its 5-year range (12.61%–136.00%).
10.63% above its 12-month average of 18.64%.
RMD Tax Rate
Reported quarterly effective tax rate; periods with non-meaningful pretax income are omitted.
RMD Average Tax Rate Chart
RMD Current vs Average Tax Rate Chart
RMD Tax Rate Metrics
TAX RATE
20.62%
TAX RATE AVG TTM
18.64%
TAX RATE AVG 3Y
19.24%
TAX RATE AVG 5Y
19.05%
TAX RATE AVG 10Y
18.57%
TAX RATE AVG 15Y
19.28%
TAX RATE AVG 20Y
21.58%
CURRENT VS TTM AVG
+10.63%
CURRENT VS 3Y AVG
+7.18%
CURRENT VS 5Y AVG
+8.23%
CURRENT VS 10Y AVG
+11.06%
CURRENT VS 15Y AVG
+6.97%
CURRENT VS 20Y AVG
-4.46%
Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Tax Rate FAQ
- What is the tax rate for ResMed Inc. (RMD)?
- The tax rate for RMD stock is 20.62%.
- Is ResMed Inc.'s tax rate high or low?
- The tax rate of 20.62% is 15% below its 5-year average of 24.32%, near the low end of its 5-year range (12.61%–136.00%).
- What is the TTM average tax rate for ResMed Inc. (RMD)?
- The TTM average tax rate for RMD stock is 18.64%.
- What is the 3Y average tax rate for ResMed Inc. (RMD)?
- The 3Y average tax rate for RMD stock is 19.24%.
- What is the 5Y average tax rate for ResMed Inc. (RMD)?
- The 5Y average tax rate for RMD stock is 19.05%.
- What is the 10Y average tax rate for ResMed Inc. (RMD)?
- The 10Y average tax rate for RMD stock is 18.57%.
- What is the 15Y average tax rate for ResMed Inc. (RMD)?
- The 15Y average tax rate for RMD stock is 19.28%.
- What is the 20Y average tax rate for ResMed Inc. (RMD)?
- The 20Y average tax rate for RMD stock is 21.58%.
RMD Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2026-03-31 | 20.62% |
| 2025-12-31 | 20.87% |
| 2025-09-30 | 21.99% |
| 2025-06-30 | 17.10% |
| 2025-03-31 | 12.61% |
| 2024-12-31 | 17.62% |
| 2024-09-30 | 18.81% |
| 2024-06-30 | 18.31% |
| 2024-03-31 | 19.96% |
| 2023-12-31 | 19.52% |
| 2023-09-30 | 19.39% |
| 2023-06-30 | 17.03% |
| 2023-03-31 | 19.66% |
| 2022-12-31 | 17.82% |
| 2022-09-30 | 19.60% |
| 2022-06-30 | 18.07% |
| 2022-03-31 | 20.90% |
| 2021-12-31 | 14.98% |
| 2021-09-30 | 21.32% |
| 2021-06-30 | 18.44% |
| 2021-03-31 | 136.00% |
| 2020-12-31 | 14.76% |
| 2020-09-30 | 17.36% |
| 2020-06-30 | 16.15% |
| 2020-03-31 | 14.88% |
| 2019-12-31 | 10.18% |
| 2019-09-30 | 20.21% |
| 2019-06-30 | 28.16% |
| 2019-03-31 | 23.57% |
| 2018-12-31 | 14.79% |
| 2018-09-30 | 23.87% |
| 2018-06-30 | 22.07% |
| 2018-03-31 | 15.38% |
| 2017-12-31 | 93.28% |
| 2017-09-30 | 20.61% |
| 2017-06-30 | 16.45% |
| 2017-03-31 | 18.67% |
| 2016-12-31 | 20.23% |
| 2016-09-30 | 18.10% |
| 2016-06-30 | 29.21% |
| 2016-03-31 | 16.70% |
| 2015-12-31 | 15.94% |
| 2015-09-30 | 16.62% |
| 2015-06-30 | 16.00% |
| 2015-03-31 | 20.44% |
| 2014-12-31 | 21.06% |
| 2014-09-30 | 18.32% |
| 2014-06-30 | 17.72% |
| 2014-03-31 | 20.32% |
| 2013-12-31 | 20.85% |
| 2013-09-30 | 20.71% |
| 2013-06-30 | 16.87% |
| 2013-03-31 | 21.37% |
| 2012-12-31 | 20.79% |
| 2012-09-30 | 21.60% |
| 2012-06-30 | 21.99% |
| 2012-03-31 | 23.09% |
| 2011-12-31 | 24.19% |
| 2011-09-30 | 24.03% |
| 2011-06-30 | 24.27% |
| 2011-03-31 | 24.88% |
| 2010-12-31 | 25.93% |
| 2010-09-30 | 25.92% |
| 2010-06-30 | 26.08% |
| 2010-03-31 | 27.82% |
| 2009-12-31 | 27.12% |
| 2009-09-30 | 27.29% |
| 2009-06-30 | 27.27% |
| 2009-03-31 | 26.86% |
| 2008-12-31 | 27.94% |
| 2008-09-30 | 27.63% |
| 2008-06-30 | 28.82% |
| 2008-03-31 | 31.86% |
| 2007-12-31 | 30.85% |
| 2007-09-30 | 28.65% |
| 2007-06-30 | 31.57% |
| 2006-12-31 | 31.36% |
| 2006-09-30 | 31.02% |
| 2006-06-30 | 40.58% |
| 2006-03-31 | 30.84% |
| 2005-12-31 | 31.44% |
| 2005-09-30 | 31.11% |
| 2005-06-30 | 32.65% |
| 2005-03-31 | 33.03% |
| 2004-12-31 | 33.39% |
| 2004-09-30 | 32.63% |
| 2004-06-30 | 32.78% |
| 2004-03-31 | 32.50% |
| 2003-12-31 | 32.32% |
| 2003-09-30 | 31.60% |
| 2003-06-30 | 32.11% |
| 2003-03-31 | 31.97% |
| 2002-12-31 | 31.69% |
| 2002-09-30 | 31.63% |
| 2002-06-30 | 32.89% |
Related Metrics
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell